These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 24270166)

  • 21. Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'.
    Jassim SA; Limoges RG
    World J Microbiol Biotechnol; 2014 Aug; 30(8):2153-70. PubMed ID: 24781265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternatives to overcoming bacterial resistances: State-of-the-art.
    Rios AC; Moutinho CG; Pinto FC; Del Fiol FS; Jozala A; Chaud MV; Vila MM; Teixeira JA; Balcão VM
    Microbiol Res; 2016 Oct; 191():51-80. PubMed ID: 27524653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-establishing a place for phage therapy in western medicine.
    Kutter EM; Kuhl SJ; Abedon ST
    Future Microbiol; 2015; 10(5):685-8. PubMed ID: 26000644
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: phage therapy: a modern tool to control bacterial infections.
    Qadir MI
    Pak J Pharm Sci; 2015 Jan; 28(1):265-70. PubMed ID: 25553704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 32. Felix d'Herelle and our microbial future.
    Keen EC
    Future Microbiol; 2012 Dec; 7(12):1337-9. PubMed ID: 23231482
    [No Abstract]   [Full Text] [Related]  

  • 33. The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.
    Abdelkader K; Gerstmans H; Saafan A; Dishisha T; Briers Y
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Framing the Future with Bacteriophages in Agriculture.
    Svircev A; Roach D; Castle A
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N
    Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.
    Wittebole X; De Roock S; Opal SM
    Virulence; 2014 Jan; 5(1):226-35. PubMed ID: 23973944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
    Torres-Barceló C
    Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.